<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Batist</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wu</surname>
    <given-names class="given-names">J. H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Spatz</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Miller</surname>
    <given-names class="given-names">W. H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Cocolakis</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Rousseau</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <etal class="etal"/>
  </person-group>. (
  <year class="year">2011</year>). 
  <article-title class="article-title">Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapies</article-title>. 
  <source class="source">Front. Pharmacol.</source>
  <volume class="volume">2</volume>:
  <fpage class="fpage">59</fpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.3389/fphar.2011.00059</pub-id>
  <?supplied-pmid 22007174?>
  <pub-id pub-id-type="pmid" class="pub-id">22007174</pub-id>
 </mixed-citation>
</ref>
